Silence Therapeutics Growth Metrics (2019-2026) | SLN

Growth Metrics Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Assets Growth (1y) (Quarter) 18.40%91.62%14.23%-2.76%-7.65%74.01%-35.13%-37.87%
Assets Growth (3y) (Quarter) 37.36%28.63%0.85%16.04%1.40%
Assets Growth (5y) (Quarter) 18.40%27.88%2.98%
Assets (QoQ) (Quarter) -8.56%-10.83%-11.16%-10.46%-12.42%
Capital Expenditures Growth (1y) (Quarter) -43.53%-95.31%
Capital Expenditures (QoQ) (Quarter) -24.71%-3.13%-93.55%1,100.00%-93.75%
Cash & Equivalents Growth (1y) (Quarter) -37.17%108.59%173.50%-50.32%-37.01%291.13%-90.71%-91.28%
Cash & Equivalents Growth (3y) (Quarter) 53.04%41.52%-5.06%6.97%-38.82%
Cash & Equivalents Growth (5y) (Quarter) 2.32%47.50%-20.82%
Cash & Equivalents (QoQ) (Quarter) -46.52%-35.67%96.53%-86.25%-49.84%
Cash from Investing Activities Growth (1y) (Quarter) 11.07%-3,532.56%234.48%-180.66%122.53%
Cash from Investing Activities (QoQ) (Quarter) 99.91%-88,597.67%273.37%-167.12%96.48%3,383.55%-204.00%118.75%
Cash from Operations Growth (1y) (Quarter) -34.63%-302.74%57.41%37.15%-26.74%
Cash from Operations (QoQ) (Quarter) 40.84%-373.41%-7.32%55.21%-76.98%49.93%-58.35%9.68%
EBITDA Margin Growth (1y) (Quarter) -2.00M-0.89M-1.45M16.61M1.63M
EBITDA Margin (QoQ) (Quarter) -0.31M0.11M0.20M-2.00M0.80M-0.45M18.26M-16.98M
EBIT Growth (1y) (Quarter) -409.03%-2.46%12.51%1,397.47%44.61%
EBIT Margin Growth (1y) (Quarter) -2.00M-0.89M-1.45M16.61M1.63M
EBIT Margin (QoQ) (Quarter) -0.31M0.11M0.20M-2.00M0.80M-0.45M18.26M-16.98M
EBIT (QoQ) (Quarter) -319.06%-28.26%85.49%-552.78%15.65%-9.52%315.16%-127.87%
EBT Growth (1y) (Quarter) -1,279.59%-40.03%40.96%-201.76%47.57%
EBT Margin Growth (1y) (Quarter) -2.01M-1.11M-1.08M-3.78M1.65M
EBT Margin (QoQ) (Quarter) -0.26M0.02M0.24M-2.01M0.64M0.05M-2.46M3.42M
EBT (QoQ) (Quarter) -844.25%-81.77%135.57%-325.96%4.16%23.36%38.69%-16.42%
Enterprise Value Growth (1y) (Quarter) 37.17%-119.92%-159.40%50.32%-38.06%-173.67%54.26%48.67%
Enterprise Value Growth (3y) (Quarter) -53.04%-41.52%-21.17%-23.36%-20.01%
Enterprise Value Growth (5y) (Quarter) -19.71%-60.67%-17.37%
Enterprise Value (QoQ) (Quarter) 26.62%16.39%10.48%16.71%17.67%
EPS (Basic) Growth (1y) (Quarter) -900.00%-35.71%40.00%-200.00%45.00%
EPS (Basic) (QoQ) (Quarter) -600.00%-78.57%136.00%-322.22%5.00%21.05%40.00%-22.22%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) -900.00%-35.71%40.00%-200.00%45.00%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) -600.00%-78.57%136.00%-322.22%5.00%21.05%40.00%-22.22%
FCF Margin Growth (1y) (Quarter) -0.86M-1.02M-0.51M-5.07M0.50M
FCF Margin (QoQ) (Quarter) -0.07M-0.10M0.16M-0.86M-0.22M0.41M-4.39M4.71M
Free Cash Flow Growth (1y) (Quarter) -34.67%-297.38%57.50%37.29%-26.70%
Free Cash Flow (QoQ) (Quarter) 39.91%-367.26%-7.29%55.30%-77.31%50.03%-58.30%9.68%
Gross Margin Growth (1y) (Quarter) -0.00M0.04M0.02M-0.00M0.00M
Gross Margin (QoQ) (Quarter) -0.04M0.02M0.02M-0.00M753.00-975.00496.000.00M
Gross Profit Growth (1y) (Quarter) -99.32%105.39%104.44%-99.91%367.05%
Gross Profit (QoQ) (Quarter) -119.98%16.92%1,186.74%-99.62%57.95%-31.65%-76.84%1,768.18%
Net Cash Flow Growth (1y) (Quarter) -176.62%-448.13%172.40%-283.18%90.12%
Net Cash Flow (QoQ) (Quarter) -105.76%-1,209.58%169.11%-247.03%58.81%272.98%-274.85%92.07%
Net Income Growth (1y) (Quarter) -1,134.00%-38.47%41.04%-204.44%47.57%
Net Income (QoQ) (Quarter) -754.46%-79.92%134.61%-331.91%4.12%23.38%38.70%-16.42%
Net Income towards Common Stockholders Growth (1y) (Quarter) -1,134.00%-38.47%41.04%-204.44%47.57%
Net Income towards Common Stockholders (QoQ) (Quarter) -754.46%-79.92%134.61%-331.91%4.12%23.38%38.70%-16.42%
Net Margin Growth (1y) (Quarter) -2.01M-1.11M-1.08M-3.78M1.65M
Net Margin (QoQ) (Quarter) -0.26M0.02M0.24M-2.01M0.64M0.05M-2.46M3.42M
Operating Income Growth (1y) (Quarter) -409.03%-2.46%12.51%1,397.47%44.61%
Operating Income (QoQ) (Quarter) -319.06%-28.26%85.49%-552.78%15.65%-9.52%315.16%-127.87%
Operating Margin Growth (1y) (Quarter) -2.00M-0.89M-1.45M16.61M1.63M
Operating Margin (QoQ) (Quarter) -0.31M0.11M0.20M-2.00M0.80M-0.45M18.26M-16.98M
Profit After Tax Growth (1y) (Quarter) -1,134.00%-38.47%41.04%-196.02%47.57%
Profit After Tax (QoQ) (Quarter) -754.46%-79.92%134.61%-331.91%4.12%23.38%43.64%-26.63%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) 286.55%30.34%-95.03%770.51%-12.84%-19.21%-13.04%-17.54%
Property, Plant & Equipment (Net) Growth (3y) (Quarter) -36.98%-17.40%-27.77%83.02%-15.08%
Property, Plant & Equipment (Net) Growth (5y) (Quarter) 13.68%-16.88%-23.34%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -6.88%4.84%-6.76%-4.47%-11.70%
Return on Assets Growth (1y) (Quarter) 0.00M0.00M0.00M0.00M0.00M
Return on Assets (QoQ) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter) 0.00M0.00M
Return on Capital Employed (QoQ) (Quarter) -494.00-472.00-581.000.00M925.00
Return on Equity Growth (1y) (Quarter) -1.00-1.000.00M-1.00-1.00
Return on Equity (QoQ) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M-1.000.00M
Return on Invested Capital Growth (1y) (Quarter) 0.00M1.00
Return on Invested Capital (QoQ) (Quarter) 0.00M0.00M0.00M1.000.00M
Return on Sales Growth (1y) (Quarter) -201.00-111.00-108.00-378.00165.00
Return on Sales (QoQ) (Quarter) -26.002.0024.00-201.0064.005.00-246.00342.00
Revenue Growth (1y) (Quarter) -99.10%-73.54%-89.39%-99.87%197.18%
Revenue (QoQ) (Quarter) -95.18%98.15%1,589.25%-99.44%40.85%-20.50%-78.62%1,141.18%
Share-based Compensation Growth (1y) (Quarter) -14.04%-49.65%-37.67%-102.16%-30.88%
Share-based Compensation (QoQ) (Quarter) 0.56%-1.79%-2.11%-11.08%-41.10%21.58%-103.39%2,945.35%
Shareholder's Equity Growth (1y) (Quarter) -40.40%-55.50%-3.92%125.26%-18.26%533.33%-28.08%-33.94%-41.54%-53.51%-56.18%
Shareholder's Equity Growth (3y) (Quarter) -36.60%-1.25%20.94%126.77%34.01%
Shareholder's Equity Growth (5y) (Quarter) -14.05%37.89%39.10%
Shareholder's Equity (QoQ) (Quarter) 640.78%-9.08%-11.11%5.78%-15.88%-16.49%-21.34%-15.88%-20.71%
Tax Rate Growth (1y) (Quarter) 113.0013.00
Tax Rate (QoQ) (Quarter) 0.00M103.00270.003.00